Have your got your EU MDR PMS & Vigilance strategy in place? 1 more year. 1 more chance.
监管Insights On PSURs. Create Robust PMS Plans. Updates On Manufacturer's Incident Reports
Overcome The Obstacles With Notified Body Advice And Practical Industry Examples
2020 Highlights: Post Market Surveillance & Vigilance
All You Need To Know
All You Need To Know
- Join Notified BodiesNSAI,IMQandTÜV SÜDto discuss their requirements for Post Market Surveillance
- Novartiswere the first company to get a CE mark for their Concept1 inhaler under the EU MDR. Hear about their first 9 months of PMS.
- Want to EU MDR proof your PMS plan? Gain leading insights fromAbbott
- Get up to date perspectives on Periodic Safety Update Reports (PSURs) with feedback fromAbbott
邮政市场报告
邮政市场报告
- Hear the latest on how the first experiences of Manufacturer Incident Reporting (MIR) have gone with Johnson and Johnson
- Telefexprovide practical insights on Serious Incident Reporting
- Update your strategies to ensure your risk management and complaint system is MDR ready withNSFandResmed
- Benefit from a joint session with the Clinical Evaluations & Investigations audience: Learn how to handle Post Market Clinical Follow-up (PMCF)
Elsewhere At The MedTech Summit...
Elsewhere At The MedTech Summit...
Take a look at the 8 other MedTech Summit conference tracks to see what else is on the agenda for you:
- Shine a light on US Post Market Safety Reporting requirements for combination products in ourDrug Device Combination Productstrack
- Be Prepared for China's increased focus on Post Market Surveillance with speakers from NMPA in theMedical Device Regulatory Affairs in Global Marketstrack
- Join ourEU Medical Device Regulationtrack toget updates, hear first-hand experiences and benchmark EU MDR implementation with your peers